These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1001403)

  • 1. Lack of effect of clofibrate on hepatic HMG-CoA reductase activity in young swine in the postabsorptive state.
    Kim DN; Rogers DH; Reiner JM; Lee KT; Thomas WA
    Exp Mol Pathol; 1976 Dec; 25(3):301-10. PubMed ID: 1001403
    [No Abstract]   [Full Text] [Related]  

  • 2. Clofibrate, inhibitor of intestinal cholesterogenesis.
    Cheng CY; Feldman EB
    Biochem Pharmacol; 1971 Dec; 20(12):3509-19. PubMed ID: 5132896
    [No Abstract]   [Full Text] [Related]  

  • 3. Colchicine inhibits hepatic cholesterol synthesis and microsomal 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA reductase) activity.
    Ottery FD; Goldfarb S
    FEBS Lett; 1976 May; 64(2):346-9. PubMed ID: 179885
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
    White LW
    J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cultured L cells by the hypocholesterolemic drug clofibrate.
    Kaneko I; Hazama-Shimada Y; Kuroda M; Endo A
    Biochem Biophys Res Commun; 1977 Jun; 76(4):1207-13. PubMed ID: 901472
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of clofibrate on the main regulatory enzymes of cholesterogenesis.
    Castillo M; Burgos C; Rodríguez-Vico F; Zafra MF; García-Peregrín E
    Life Sci; 1990; 46(6):397-403. PubMed ID: 2154659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2589-600. PubMed ID: 9409231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of action of the lipid-lowering agents, clofibrate and BM 15075, on cholesterol biosynthesis in rat liver.
    Berndt J; Gaumert R; Still J
    Atherosclerosis; 1978 Jun; 30(2):147-52. PubMed ID: 678316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of streptozotocin diabetes on intestinal 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in the rat.
    Nakayama H; Nakagawa S
    Diabetes; 1977 May; 26(5):439-44. PubMed ID: 140087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement by dietary clofibrate of peroxisomal palmityl-CoA oxidase in kidney and small intestine of albino mice and liver of genetically lean and obese mice.
    Small GM; Hocking TJ; Strudee AP; Burdett K; Connock MJ
    Life Sci; 1981 Apr; 28(17):1875-82. PubMed ID: 7253794
    [No Abstract]   [Full Text] [Related]  

  • 11. Apoptosis induced by clofibrate in Yoshida AH-130 hepatoma cells: role of HMG-CoA reductase.
    Canuto RA; Muzio G; Maggiora M; Trombetta A; Martinasso G; Autelli R; Costelli P; Bonelli G; Baccino FM
    J Lipid Res; 2003 Jan; 44(1):56-64. PubMed ID: 12518023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the small intestine in cholesterol metabolism.
    McIntyre N; Isselbacher KJ
    Am J Clin Nutr; 1973 Jun; 26(6):647-56. PubMed ID: 4350610
    [No Abstract]   [Full Text] [Related]  

  • 13. Bile acid derived HMG-CoA reductase inhibitors.
    Kramer W; Wess G; Enhsen A; Bock K; Falk E; Hoffmann A; Neckermann G; Gantz D; Schulz S; Nickau L
    Biochim Biophys Acta; 1994 Nov; 1227(3):137-54. PubMed ID: 7986821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antilipidemic properties of cis-7-chloro-3a, 8b-dihydro-3a-methylfuro[3,4-b]benzofuran-3(1H)-one, a tricyclic clofibrate related lactone having a structural resemblance to mevalonolactone.
    Witiak DT; Kuwano E; Feller DR; Baldwin JR; Newman HA; Sankrappa SK
    J Med Chem; 1976 Oct; 19(10):1214-20. PubMed ID: 994152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of diet and lovastatin on regression of fatty streak lesions and on hepatic and intestinal mRNA levels for the LDL receptor and HMG CoA reductase in F1B hamsters.
    Pitman WA; Osgood DP; Smith D; Schaefer EJ; Ordovas JM
    Atherosclerosis; 1998 May; 138(1):43-52. PubMed ID: 9678770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-term administration of HMG-CoA reductase inhibitors on cholesterol synthesis in lens.
    Kalinowski SS; Tanaka RD; Mosley ST
    Exp Eye Res; 1991 Aug; 53(2):179-86. PubMed ID: 1915674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological feedback regulation of cholesterol biosynthesis: Role of translational control of hepatic HMG-CoA reductase and possible involvement of oxylanosterols.
    Ness GC
    Biochim Biophys Acta; 2015 May; 1851(5):667-73. PubMed ID: 25701719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tannic acid is more effective than clofibrate for the elevation of hepatic β-oxidation and the inhibition of 3-hydroxy-3-methyl-glutaryl-CoA reductase and aortic lesion formation in apo E-deficient mice.
    Do GM; Kwon EY; Ha TY; Park YB; Kim HJ; Jeon SM; Lee MK; Choi MS
    Br J Nutr; 2011 Dec; 106(12):1855-63. PubMed ID: 21736774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clofibrate on sterol metabolism in the rat.
    Cohen BI; Raicht RF; Shefer S; Mosbach EH
    Biochim Biophys Acta; 1974 Oct; 369(1):79-85. PubMed ID: 4418670
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of rat liver hydroxymethylglutaryl coenzyme A reductase by a new class of noncompetitive inhibitors. Effects of dichloroacetate and related carboxylic acids on enzyme activity.
    Stacpoole PW; Harwood HJ; Varnado CE
    J Clin Invest; 1983 Nov; 72(5):1575-85. PubMed ID: 6630519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.